Russia’s Covid vaccine Sputnik-V has been cleared for emergency use approval in India by a committee of experts in the middle of a record spike in virus cases in the country.
If approved by regulator DGCI, this will become the third vaccine to be used in India after Serum Institute of India’s Covishield – developed by Oxford-AstraZeneca – and Bharat Biotech’s Covaxin.
Gold Rate
May 14- 2026 - Time 10.30Hrs
Gold 24 KT
₹ 159,100 /-
Gold 22 KT
₹ 1,48,000 /-
Silver/Kg
₹ 2,70,400/-
Platinum
₹ 88,000/-
Recommended rate for Nagpur sarafa Making charges minimum 13% and above
Sputnik-V, manufactured in India by Dr Reddy’s, has the highest effectiveness – 91.6 per cent — after the Moderna and Pfizer shots.
Advertisement
Advertisement
Advertisement
